Abstract
Tizanidine hydrochloride is a skeletal muscle relaxant used for the treatment of spasm, a sudden involuntary muscle contraction leading to pain. The presently available oral dosage form has limitations such as high first pass metabolism resulting in low oral bioavailability. The short half-life necessitates its frequent administration to maintain the required plasma concentration. Transdermal delivery of drug avoids its first pass hepatic metabolism and gives controlled release, making it possible for reduction in dosing frequency. Drug delivery through transdermal route is severely limited by the presence of a tough stratum corneum barrier. A penetration enhancement approach is often necessary to achieve desired plasma concentrations. Microneedles are very short and sharp needles which do not cause pain. Thus, in the present investigation, preparation and evaluation of a transdermal delivery system for tizanidine hydrochloride based on microneedles are described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alkilani A, McCrudden MT, Donnelly R (2015) Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 7(4):438–470
Tanwar H, Sachdeva R (2016) Transdermal drug delivery system: a review. Int J Pharm Sci Res 7:2274–2290
Dharadhar S, Majumdar A, Dhoble S, Patravale V (2019) Microneedles for transdermal drug delivery: a systematic review. Drug Dev Ind Pharm 45(2):188–201
Prausnitz MR (2004) Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56(5):581–587
Indermun S, Luttge R, Choonara YE, Kumar P, Du Toit LC, Modi G et al (2014) Current advances in the fabrication of microneedles for transdermal delivery. J Control Release 185:130–138
Ita K (2015) Transdermal delivery of drugs with microneedles—potential and challenges. Pharmaceutics 7(3):90–105
Donnelly RF, Singh TRR, Woolfson AD (2010) Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv 17(4):187–207
Kim Y-C, Park J-H, Prausnitz MR (2012) Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 64(14):1547–1568
Kaushik D, Kilfoyle B, Thakur R, Michniak-Kohn BB (2010) Microneedles–minimally invasive transdermal delivery technology. In: Handbook of non-invasive drug delivery systems. Elsevier, Amsterdam, pp 135–164
Wang M, Hu L, Xu C (2017) Recent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing. Lab Chip 17(8):1373–1387
Hegde NR, Kaveri SV, Bayry J (2011) Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination. Drug Discov Today 16(23-24):1061–1068
van der Maaden K, Jiskoot W, Bouwstra J (2012) Microneedle technologies for (trans) dermal drug and vaccine delivery. J Control Release 161(2):645–655
Nagadevi B, Kumar KS, Venkanna P, Prabhakar D (2014) Formulation and characterisation of tizanidine hydrochloride loaded ethosomes patch. Int J Pharm Pharm Sci 6(4):199–205
Tse F, Jaffe J, Bhuta S (1987) Pharmacokinetics of orally administered tizanidine in healthy volunteers. Fundam Clin Pharmacol 1(6):479–488
Bediz B, Korkmaz E, Khilwani R, Donahue C, Erdos G, Falo LD et al (2014) Dissolvable microneedle arrays for intradermal delivery of biologics: fabrication and application. Pharm Res 31(1):117–135
Amodwala S, Kumar P, Thakkar HP (2017) Statistically optimized fast dissolving microneedle transdermal patch of meloxicam: a patient friendly approach to manage arthritis. Eur J Pharm Sci 104:114–123
Wang QL, Zhu DD, Chen Y, Guo XD (2016) A fabrication method of microneedle molds with controlled microstructures. Mater Sci Eng C 65:135–142
Kathuria H, Li H, Pan J, Lim SH, Kochhar JS, Wu C et al (2016) Large size microneedle patch to deliver lidocaine through skin. Pharm Res 33(11):2653–2667
Akhtar N (2014) Microneedles: an innovative approach to transdermal delivery—a review. Int J Pharm Pharm Sci 6:18–25
Silva CL, Topgaard D, Kocherbitov V, Sousa J, Pais AA, Sparr E (2007) Stratum corneum hydration: phase transformations and mobility in stratum corneum, extracted lipids and isolated corneocytes. Biochim Biophys Acta 1768(11):2647–2659
Dąbrowska A, Rotaru GM, Spano F, Affolter C, Fortunato G, Lehmann S et al (2017) A water-responsive, gelatine-based human skin model. Tribol Int 113:316–322
Raj Singh TR, Garland MJ, Migalska K, Salvador EC, Shaikh R, McCarthy HO et al (2012) Influence of a pore-forming agent on swelling, network parameters, and permeability of poly (ethylene glycol)-crosslinked poly (methyl vinyl ether-co-maleic acid) hydrogels: application in transdermal delivery systems. J Appl Polym Sci 125(4):2680–2694
Thakkar H, Savsani H, Kumar P (2016) Ethosomal hydrogel of raloxifene HCl: statistical optimization & ex vivo permeability evaluation across microporated Pig ear skin. Curr Drug Deliv 13(7):1111–1122
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Thakkar, H., Pandya, K., Patel, B. (2020). Microneedle-Mediated Transdermal Delivery of Tizanidine Hydrochloride. In: Jain, K. (eds) Drug Delivery Systems. Methods in Molecular Biology, vol 2059. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9798-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9798-5_13
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9797-8
Online ISBN: 978-1-4939-9798-5
eBook Packages: Springer Protocols